Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1979 Dec 1;183(3):615-22.
doi: 10.1042/bj1830615.

Limited proteolysis of complement components C2 and factor B. Structural analogy and limited sequence homology

Comparative Study

Limited proteolysis of complement components C2 and factor B. Structural analogy and limited sequence homology

M A Kerr. Biochem J. .

Abstract

A method is described for the simultaneous purification of milligram quantities of complement components C2 and Factor B. Both products are homogeneous by the criteria of polyacrylamide-gel electrophoresis and N-terminal sequence analysis. Component C2 is cleaved by serine proteinase C1s at an X-Lys bond to give fragment C2a (approx. mol.wt. 74000) and fragment C2b (approx. mol.wt. 34000). The two fragments can be separated by gel filtration without the need for reducing or denaturing agents. Fragment C2b represents the N-terminal end of the molecule. Similar results were seen on cleavage of Factor B by Factor D in the presence of component C3. Again two non-covalently linked fragments are formed. The smaller, fragment Ba (approx. mol.wt. 36,000),) has threonine as the N-terminal residue, as does Factor B; the larger, fragment Bb (approx. mol. wt. 58000), has lysine as the N-terminal residue. A similar cleavage pattern is obtained on limited proteolysis of Factor B by trypsin, suggesting an Arg-Lys-or Lys-Lys bond at the point of cleavage. Although component C2 and Factor B show no apparent N-terminal sequence homology, a limited degree of sequence homology is seen around the sites of proteolytic cleavage.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Scand J Immunol. 1976;5(9):1049-55 - PubMed
    1. Biochemistry. 1977 Nov 29;16(24):5368-75 - PubMed
    1. Biochem J. 1978 Apr 1;171(1):99-107 - PubMed
    1. Proc Natl Acad Sci U S A. 1977 Jul;74(7):2998-3001 - PubMed
    1. Trans Assoc Am Physicians. 1977;90:174-83 - PubMed

Publication types